A new type of ferrocene-based phosphine-tert-butylsulfinamide ligand: synthesis and application in asymmetric catalysis

Jiangwei Ma, Chuang Li, Dongxu Zhang, Yang Lei, Muqiong Li, Ru Jiang* and Weiping Chen*
School of Pharmacy, Fourth Military Medical University, 169 Changle West Road, Xi'an, 710032, PR China. E-mail: jiangru@fmmu.edu.cn; wpchen@fmmu.edu.cn

Received 17th February 2015 , Accepted 14th April 2015

First published on 14th April 2015


Abstract

A new type of ferrocene-based phosphine-tert-butylsulfinamide ligand has been synthesized and applied to the enantioselective formation of C–C and C–N bonds. The palladium complex derived from ligand 4a was an efficient catalyst in asymmetric allylic substitution of several substrate types. Enantioselectivites with the difficult substrate 3-acetoxycyclohexene of up to 91% ee are achieved.


Chiral ligands have been considered one of the most important topics in asymmetric catalysis over the last three decades owing to their fruitful applications in asymmetric synthesis.1 Among the thousands of chiral ligands prepared, bidentate ligands have become the most powerful tool in metal-catalyzed asymmetric processes since chelation provides the rigidity required to firmly allocate the chiral information around the metal center. Usually, the chirality of most bidentate ligands resides in the carbon backbone. However, some have a chiral phosphorus or sulfur center, and few have both a chiral scaffold and a chiral phosphorus or sulfur center. The ligands with chirality at the metal-coordinating atom, which bring the chiral information into the closest possible proximity to the catalytic center, might increase enantioselectivities of the catalytic transformations that the catalyst is mediating. Indeed, P-stereogenic bidentate diphosphine ligands are extremely proficient in asymmetric transformations.2 However, the synthesis of chiral-phosphorus ligands is often complex and difficult. In contrast, the preparation of chiral sulfur compounds is more convenient and several chiral sulfoxides and sulfinamides are commercially available.3 Pioneered by Ellman,4 both enantiomers tert-butylsulfinamide is now available in large amounts and is used as a sacrificial chiral auxiliary in a wide range of synthetic processes.5 The ease of synthesis, stability, resident chirality, and potential for metal coordination of the S, N and O atoms of N-tert-butanesulfinamides also provides excellent opportunities for the development of N-sulfinyl-based ligands for asymmetric catalysis.6

However, the ligands containing a sulfinamide moiety are rare.7 Verdaguer reported ligand 1 for the intermolecular asymmetric Pauson–Khand reaction and ligand 2 for asymmetric hydrogenation (Fig. 1).8 These ligands coordinate readily to rhodium, palladium and other metals to give either P,O or P,S bidentate coordination.9 Recently, ligand 3 was developed and applied in the Pd-catalyzed asymmetric allylic alkylation by Bolm.10 Very recently, Zhang described Ming-Phos for the enantioselective gold-catalyzed cycloaddition reaction of 2-(1-alkynyl)-alk-2-en-1-ones with nitrones.11 As a part of our continuous research on the development of ferrocene-based chiral ligands and catalysts,12 we are interested in exploring the potential of ferrocene-based bidentate ligands containing tert-butylsulfinamide moiety. Herein, we describe the synthesis of ferrocene-based phosphine-tert-butylsulfinamide ligands 4 and the preliminary results of their palladium complexes catalyzed asymmetric allylic substitution reaction.


image file: c5ra03010b-f1.tif
Fig. 1 Known phosphine-tert-butylsulfinamide ligands.

Phosphine-tert-butylsulfinamide 4 was easily synthesized from (R)-Ugi's amine 5 in three steps (Scheme 1). Highly diastereoselective ortho-lithiation of 5 followed by treatment with ClPR2 gave compound 6, which was transformed into aminophosphine 7 by reaction with Ac2O, and then ammonolysis with a large excess of ammonia or amine.13 Ligand 4a–g were obtained by sulfinylation of the lithium salts of 7 (formed in situ by deprotonation of 7 with n-BuLi) using an enantiopure tert-butanethiosulfinate. These ligands were characterized by 1H NMR, 13C NMR, 31P NMR and mass spectrometry.


image file: c5ra03010b-s1.tif
Scheme 1 Synthesis of ligand 4.

We first tested the ligands in the Pd-catalyzed asymmetric allylic alkylation of racemic (E)-1,3-diphenylallyl acetate 8a with dimethyl malonate 9 as a model reaction using standard conditions (Table 1). The results indicated that the chiralities of ferrocenyl moiety in the ligands play the decisive role in the Pd-catalyzed asymmetric allylic alkylation, giving (R)-10a (Table 1, entries 1–6). While the carbon-centred chirality and the planar chirality of ferrocene scaffold are the main governing factors, the sulfur-centred chirality of sulfinamide moiety is also important, and (RC,SFc,RS)-4 are the ligands with the matched chiralities (entry 1 vs. 6).

Table 1 Screening of the ligands in asymmetric allylic alkylationa

image file: c5ra03010b-u1.tif

Entry Ligand Yieldb (%) eec (%)
a The reaction was conducted with rac-(E)-1,3-diphenylallyl acetate 8a (0.4 mmol), dimethyl malonate 9 (1.2 mmol) [Pd(C3H5)Cl]2 (0.008 mmol), ligand 4 (0.024 mmol), BSA (1.2 mmol), LiOAc (0.034 mmol) in THF at 25 °C.b Isolated yields.c Determined by chiral HPLC analysis using a chiral column (Chiralcel AD-H column, hexane/i-propanol = 80[thin space (1/6-em)]:[thin space (1/6-em)]20). Absolute configuration was assigned by comparing the optical rotation values with those reported in the literature.
1 4a 65 77(R)
2 4b 34 5(R)
3 4c 65 67(R)
4 4d 52 71(R)
5 4e 35 52(R)
6 4f 75 27(R)
7 4g 36 9(S)


Notably, when replacement of NH of sulfinamide moiety with N-Me, both the activity and enantioselectivity decreased dramatically, suggesting that a sterically bulky substituent is disfavoured or a hydrogen-bonding donor is essential for the stereoinduction (Table 1, entries 1 vs. 2, 6 vs. 7). With regard to the effect of the P-substituents, the aryl groups were highly beneficial in terms of enantioselectivity and catalytic activities (Table 1, entries 1, 3, 4 vs. 5). But the bulky aryl groups had a deleterious effect on enantioselectivity (Table 1, entries 1 vs. 3, 4).

To further improve the chemical yield and enantioselectivity, we optimized the reaction conditions. The effect of solvent, reaction temperature, base and additives on the catalytic activity and enantioselectivity were investigated using 4a as the ligand. As shown in Table 2, the solvent was observed to play a crucial role, and THF proved to be superior.

Table 2 The effect of solvents on the asymmetric allylic alkylation using ligand 4aa

image file: c5ra03010b-u2.tif

Entry Solvent Yieldb (%) eec (%)
a The reaction was conducted with rac-(E)-1,3-diphenylallyl acetate 8a (0.4 mmol), dimethyl malonate 9 (1.2 mmol) [Pd(C3H5)Cl]2 (0.008 mmol), 4a (0.024 mmol), BSA (1.2 mmol), LiOAc (0.034 mmol) in solvent at 25 °C.b Isolated yields.c Determined by chiral HPLC analysis using a chiral column (Chiralcel AD-H column, hexane/i-propanol = 80[thin space (1/6-em)]:[thin space (1/6-em)]20).
1 CH2Cl2 63 49
2 THF 65 77
3 Toluene 73 55
4 ClCH2CH2Cl 66 73
5 Dioxane 63 65
6 Et2O 29 55
7 DMF 72 72
8 CH3CN 55 41


It is noteworthy that the base has a pronounced influence on the catalytic performance (Table 3). The reaction proceeded quickly in the presence of strong bases, such as n-BuLi, NaH, or KOH, but the enantioselectivities were poor (Table 4, entries 2–4). When N,O-bis(trimethylsilyl)acetamide (BSA) was used as a base and a catalytic amount of salt as an additive,14 enantioselectivities were improved significantly, while chemical yield decreased slightly (Table 3, entries 7–13). Interestingly, the highest enantioselectivity were achieved in 89% ee when BSA was used as a base in the absence of salt additives (Table 3, entry 14). Examination of the temperature effects revealed that 25 °C was optimal for the reaction (Table 3, entries 14 vs. 15, 16).

Table 3 Further optimization of reaction conditionsa

image file: c5ra03010b-u3.tif

Entry Base Additive (mol%) Temperature (°C) Yieldb (%) eec (%)
a The reaction was conducted with rac-(E)-1,3-diphenylallyl acetate 8a (0.4 mmol), dimethyl malonate 9 (1.2 mmol), [Pd(C3H5)Cl]2 (0.008 mmol), 4a (0.024 mmol), base (1.2 mmol), additive in THF 25 °C.b Isolated yields.c Determined by chiral HPLC analysis using a chiral column (Chiralcel AD-H column, hexane/i-propanol = 80[thin space (1/6-em)]:[thin space (1/6-em)]20). The absolute configuration was determined by comparing the specific rotation with a literature value.
1 None None 25 15 43(R)
2 n-BuLi None 25 77 11(R)
3 NaH None 25 65 12(S)
4 KOH None 25 70 33(S)
5 Cs2CO3 None 25 59 29(S)
6 K2CO3 None 25 40 rac
7 BSA LiOAc (9) 25 70 77(R)
8 BSA LiOAc (6) 25 69 81(R)
9 BSA LiOAc (3) 25 66 82(R)
10 BSA NaOAc (9) 25 60 71(R)
11 BSA KOAc (9) 25 62 51(R)
12 BSA CsOAc (9) 25 45 67(R)
13 BSA AgOAc (9) 25 55 74(R)
14 BSA None 25 60 89(R)
15 BSA None 40 64 84(R)
16 BSA None 0 30 75(R)


Table 4 Scope of asymmetric allylic alkylation using ligand 4aa

image file: c5ra03010b-u4.tif

Entry Ar NuH Yieldb (%) eec (%)
a The reaction was conducted with rac-(E)-1,3-diarylallyl acetate 8 (0.4 mmol), NuH (1.2 mmol), [Pd(C3H5)Cl]2 (0.008 mmol), 4a (0.024 mmol), BSA (1.2 mmol) in solvent at 25 °C.b Isolated yields.c Determined by chiral HPLC analysis using a chiral column. (Entry 1: Chiralcel AD-H column, hexane/i-propanol = 80[thin space (1/6-em)]:[thin space (1/6-em)]20; entry 2: Chiralcel AD-H column, hexane/i-propanol = 93[thin space (1/6-em)]:[thin space (1/6-em)]7; entry 3: Chiralcel AD-H + AD-H column, hexane/i-propanol = 99[thin space (1/6-em)]:[thin space (1/6-em)]1; entry 4: Chiralcel AD-H column, hexane/i-propanol = 99[thin space (1/6-em)]:[thin space (1/6-em)]1; entry 5: Chiralcel AD-H column, hexane/i-propanol = 94[thin space (1/6-em)]:[thin space (1/6-em)]6; entry 6: Chiralcel AD-H column, hexane/i-propanol = 85[thin space (1/6-em)]:[thin space (1/6-em)]15).
1 C6H5 (8a) CH2(COOMe)2 62 89
2 C6H5 (8a) CH2(COOEt)2 65 88
3 C6H5 (8a) CH(CH3)(COOMe)2 55 76
4 C6H5 (8a) Acetylacetone 41 29
5 4-MeC6H4 (8b) CH2(COOMe)2 55 62
6 4-ClC6H4 (8c) CH2(COOMe)2 59 78


Encouraged by these results, our attention focused on investigating the scope of this catalytic system, various nucleophiles and substrates were screened. When CH2(CO2Et)2 was used as the nucleophile instead of CH2(CO2Me)2, the yield and enantioselectivity were maintained (Table 4, entry 2). But bulky nucleophile decreased the ee value of product 10 (Table 4, entry 3). Employing acetylacetone as nucleophile led to a significant drop in the enantioselectivity and chemical yield (Table 4, entry 4). On the other hand, diarylallyl acetate 8 bearing either the electron-donating or electron-withdrawing substituents on the aromatic ring underwent the reaction smoothly to give the desired products in good levels of enantioselectivities (Table 4, entries 5, 6).

To further study the potential of ligand 4a, we also tested it in the asymmetric allylic alkylation of more challenging unhindered cyclic substrate 11 and unsymmetrical disubstituted linear substrates 13, 15 (Scheme 2). To the best of our knowledge, few catalysts were efficient for asymmetric allylic alkylation of these substrates.10,15 Importantly, high enantioselectivity (91% ee) was obtained in the allylic alkylation of difficult substrate 11. For substrates 13 and 15, the catalytic system showed dissatisfactory regioselectivity, but ee value of each isomer were moderate to high.


image file: c5ra03010b-s2.tif
Scheme 2 Asymmetric allylic alkylation of challenging substrates using ligand 4a.

Having achieved enantioselective C–C bond formation, we also evaluated the chiral phosphine-tert-butylsulfinamide ligands in a C–N bond formation reaction. In the presence of ligand 4, rac-(E)-1,3-diphenylallyl acetate 8a was reacted with benzylamine under conditions similar to those of alkylation described above. Ligand 4a and THF were also the best ligand and solvent, respectively. Similarly, BSA was the best base, but 15 mol% NaOAc was necessary for the best enantioselectivity (Table 5, entry 10). Screening of various palladium precursors indicated that [Pd2(dba)3]CHCl3 was superior to [Pd(C3H5)Cl]2 and Pd2(dba)3 (Table 5, entries 6 vs. 2, 4). With the reaction conditions optimized, other amines were also examined in this reaction. Moderate enantioselectivities were also obtained (Table 5, entries 11, 12).

Table 5 Pd-catalyzed asymmetric allylic aminations using ligand 4aa

image file: c5ra03010b-u5.tif

Entry Pd R1R2NH Base Additive (mol%) Yieldb (%) eec (%)
a The reaction was conducted with rac-(E)-1,3-diphenylallyl acetate 8a (0.4 mmol), R1R2NH 17 (1.2 mmol), palladium precursor (0.008 mmol), 4a (0.024 mmol), BSA (1.2 mmol) and additive in solvent at 25 °C.b Isolated yields.c Determined by chiral HPLC analysis using a chiral column. (Entries 1–10: Chiralcel AD-H column, hexane/i-propanol = 90[thin space (1/6-em)]:[thin space (1/6-em)]10; entry11: Chiralcel OD-H column, hexane/i-propanol = 90[thin space (1/6-em)]:[thin space (1/6-em)]10; entry12: Chiralcel OD-H column, hexane/i-propanol = 90[thin space (1/6-em)]:[thin space (1/6-em)]10). Absolute configuration was assigned by comparing the optical rotation values with those reported in the literature.
1 Pd2(dba)3 Benzylamine None None 47 9(R)
2 Pd2(dba)3 Benzylamine BSA NaOAc (9) 31 rac
3 [Pd(C3H5)Cl]2 Benzylamine None None 53 37(R)
4 [Pd(C3H5)Cl]2 Benzylamine BSA NaOAc (9) 40 13(S)
5 [Pd2(dba)3]CHCl3 Benzylamine None None 32 17(R)
6 [Pd2(dba)3]CHCl3 Benzylamine BSA NaOAc (9) 43 82(R)
7 [Pd2(dba)3]CHCl3 Benzylamine BSA LiOAc (9) 40 43(R)
8 [Pd2(dba)3]CHCl3 Benzylamine BSA KOAc (9) 55 49(R)
9 [Pd2(dba)3]CHCl3 Benzylamine BSA NaOAc (6) 40 65(R)
10 [Pd2(dba)3]CHCl3 Benzylamine BSA NaOAc (15) 45 87(R)
11 [Pd2(dba)3]CHCl3 Morpholine BSA NaOAc (15) 72 55(R)
12 [Pd2(dba)3]CHCl3 p-Methoxy aniline BSA NaOAc (15) 16 74(R)


A plausible mechanism for the asymmetric induction with chiral phosphine-tert-butylsulfinamide ligand 4a was proposed on the basis of the stereochemical results obtained. A seven-membered chelated π-allylpalladium complex would be formed by coordination of the phosphine and the sulfinamide to palladium. The W-type π-allyl complex 19 would be more stable than the M-type complex 20, which has repulsive interaction between the two phenyl groups in substrate 8 with the t-butyl group on the S atom and two phenyl groups on the P atom. The nucleophile would preferentially attack the allylic terminal carbon trans to phosphorus affording (R)-isomer (Fig. 2). Similarly, the transition state 21 would be more stable than 22 to provide (R)-isomer for the cyclic substrate 11.


image file: c5ra03010b-f2.tif
Fig. 2 Plausible transition state for the allylic alkylation using ligand 4a.

Conclusions

A new type of ferrocene-based phosphine-tert-butylsulfinamide ligands have been synthesized and applied to the enantioselective formation of C–C and C–N bond. The palladium complex derived from ligand 4a was an efficient catalyst in asymmetric allylic alkylation of symmetrical disubstituted linear substrates (up to 89% ee), unsymmetrical disubstituted linear substrates (up to 89% ee) and unhindered cyclic substrate (up to 91% ee). For the asymmetric allylic amination, good stereoselectivities were also obtained (up to 87% ee). Further studies focusing on the modification of the ligands and applications in other catalytic reactions are currently underway in our laboratory.

Acknowledgements

We thank the National Natural Science Foundation of China (21272271, 21472240) and Natural Science Foundation of Shannxi Province (2014JM2-8192) for financial support.

Notes and references

  1. (a) T. P. Yoon and E. N. Jacobsen, Science, 2003, 299, 1691 CrossRef CAS PubMed; (b) I. Ojima, Catalytic Asymmetric Synthesis, Wiley-VCH, New York, 2nd edn, 2000 Search PubMed; (c) E. J. Jacobsen, A. Pfaltz and H. Yamamoto, Comprehensive Asymmetric Catalysis, Springer, New York, 1999 Search PubMed.
  2. (a) A. Grabulosa, J. Granell and G. Muller, Coord. Chem. Rev., 2007, 251, 25 CrossRef CAS PubMed; (b) A. Grabulosa, P-Stereogenic Ligands in Asymmetric Catalysis, RSC Publishing, Cambridge, 2011 Search PubMed.
  3. I. Fernandez and N. Khiar, Chem. Rev., 2003, 103, 3651 CrossRef CAS PubMed.
  4. G. Liu, D. A. Cogan and J. A. Ellman, J. Am. Chem. Soc., 1997, 119, 9913 CrossRef CAS.
  5. For reviews on the applications of N-tert-butanesulfinamides and N-tert-butanesulfinylimines, see: (a) J. A. Ellman, Pure Appl. Chem., 2003, 75, 39 CrossRef CAS; (b) M. T. Robak, M. A. Herbage and J. A. Ellman, Chem. Rev., 2010, 110, 3600 CrossRef CAS PubMed; (c) H. Dong, M. Xu, C. Feng, X. Sun and G. Lin, Org. Chem. Front., 2015, 2, 73 RSC.
  6. (a) T. Owens, F. Hollander, A. Oliver and J. Ellman, J. Am. Chem. Soc., 2001, 123, 1539 CrossRef CAS; (b) A. Souers, T. Owens, A. Oliver, F. Hollander and J. Ellman, Inorg. Chem., 2001, 40, 5299 CrossRef CAS; (c) M. Mellah, A. Voituriez and E. Schulz, Chem. Rev., 2007, 107, 5133 CrossRef CAS PubMed; (d) C. Worch, A. C. Mayer and C. Bolm, Organosulfur Chemistry in Asymmetric Synthesis, ed. T. Toru and C. Bolm, 2008 Search PubMed.
  7. For review on the sulfoxide and N-sulfinyl ligands, see: F. Xue, C. G. Li, J. Chen and B. S. Wan, Chin. J. Org. Chem., 2014, 34, 267 CrossRef CAS.
  8. (a) J. Solà, M. Revés, A. Riera and X. Verdaguer, Angew. Chem., Int. Ed., 2007, 46, 5020 CrossRef PubMed; (b) M. Revés, T. Achard, J. Solà, A. Riera and X. Verdaguer, J. Org. Chem., 2008, 73, 7080 CrossRef PubMed; (c) Y. Ji, A. Riera and X. Verdaguer, Org. Lett., 2009, 11, 4346 CrossRef CAS PubMed; (d) A. Vázquez-Romero, J. Rodríguez, A. Lledó, X. Verdaguer and A. Riera, Org. Lett., 2008, 10, 4509 CrossRef PubMed; (e) S. Doran, T. Achard, A. Riera and X. Verdaguer, J. Organomet. Chem., 2012, 717, 135 CrossRef CAS PubMed.
  9. (a) T. Achard, J. Benet-Buchholz, A. Riera and X. Verdaguer, Organometallics, 2009, 28, 480 CrossRef CAS; (b) T. Achard, J. Benet-Buchholz, E. C. Escudero-Adán, A. Riera and X. Verdaguer, Organometallics, 2011, 30, 3119 CrossRef CAS.
  10. E. B. Benetskiy and C. Bolm, Tetrahedron: Asymmetry, 2011, 22, 373 CrossRef CAS PubMed.
  11. Z. Zhang, P. Chen, W. Li, Y. Niu, X. Zhao and J. Zhang, Angew. Chem., Int. Ed., 2014, 53, 4350 CrossRef CAS PubMed.
  12. (a) W. Chen, W. Mbafor, S. M. Roberts and J. Whittall, J. Am. Chem. Soc., 2006, 128, 3922 CrossRef CAS PubMed; (b) W. Chen, S. M. Roberts, J. Whittall and A. Steiner, Chem. Commun., 2006, 2916 RSC; (c) W. Chen, P. J. McCormack, K. Mohammed, W. Mbafor, S. M. Roberts and J. Whittall, Angew. Chem., Int. Ed., 2007, 46, 4141 CrossRef CAS PubMed; (d) W. Chen, F. Spindler, B. Pugin and U. Nettekoven, Angew. Chem., Int. Ed., 2013, 52, 8652 CrossRef CAS PubMed; (e) H. Nie, G. Zhou, Q. Wang, W. Chen and S. Zhang, Tetrahedron: Asymmetry, 2013, 24, 1567 CrossRef CAS PubMed; (f) Q. Wang, X. Liu, X. Liu, B. Li, H. Nie, S. Zhang and W. Chen, Chem. Commun., 2014, 50, 978 RSC; (g) X. Zhang, P. Ma, D. Zhang, Y. Lei, S. Zhang, R. Jiang and W. Chen, Org. Biomol. Chem., 2014, 12, 2423 RSC; (h) W. Yao, M. Chen, X. Liu, R. Jiang, S. Zhang and W. Chen, Catal. Sci. Technol., 2014, 4, 1726 RSC; (i) H. Nie, L. Yao, B. Li, S. Zhang and W. Chen, Organometallics, 2014, 33, 2109 CrossRef CAS.
  13. W. Chen, W. Mbafor, S. M. Roberts and J. Whittall, Tetrahedron: Asymmetry, 2006, 17, 1161 CrossRef CAS PubMed.
  14. The synergistic effect of an additive in asymmetric catalysis is not unusual: (a) H. Ren and W. D. Wulff, J. Am. Chem. Soc., 2011, 133, 5656 CrossRef CAS PubMed; (b) H. Ren and W. D. Wulff, Org. Lett., 2013, 15, 242 CrossRef CAS PubMed; (c) C. Azap and M. Rueping, Angew. Chem., Int. Ed., 2006, 45, 7832 CrossRef PubMed.
  15. (a) J. Mazuela, O. Pàmies and M. Diéguez, ChemCatChem, 2013, 5, 1504 CrossRef CAS PubMed; (b) M. Diéguez and O. Pàmies, Acc. Chem. Res., 2010, 43, 311 CrossRef PubMed; (c) X. Meng, Y. Gao, X. Li and D. Xu, Catal. Commun., 2009, 10, 950 CrossRef CAS PubMed; (d) L. Du, P. Cao, J. Xing, Y. Lou, L. Jiang, L. Li and J. Liao, Angew. Chem., Int. Ed., 2013, 52, 4207 CrossRef CAS PubMed; (e) H. Cheng, B. Feng, L. Chen, W. Guo, X. Yu, L. Lu, J. Chen and W. Xiao, Chem. Commun., 2014, 50, 2873 RSC , ESI..

Footnote

Electronic supplementary information (ESI) available. See DOI: 10.1039/c5ra03010b

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.